New imaging tool could sharpen liver tumor embolization

NCT ID NCT06971991

Recruiting now Knowledge-focused Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new imaging method called qDSA that measures blood flow in real time during liver embolization, a procedure that blocks blood supply to tumors. Up to 20 participants will have qDSA and ultrasound images taken before, during, and after the procedure. The goal is to see if qDSA can help doctors confirm the right amount of blood flow reduction, potentially improving treatment precision.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this technique could help doctors more precisely block blood flow to liver tumors during embolization procedures.
What could go wrong: This is a very small, early-stage study (20 people) focused on measuring blood flow, not on treating the disease itself. The technique may not prove useful or practical in routine care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

liver and intrahepatic bile duct neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RADIOEMBOLIZATION TRANSARTERIAL CHEMOEMBOLIZATION TRANSARTERIAL EMBOLISM

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

UW Hospital and Clinics
RECRUITING

Madison, Wisconsin, 53792, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.